Reviva Pharmaceuticals Holdings, Inc (RVPH) insider trading
Every open-market stock purchase and sale by Reviva Pharmaceuticals Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Purav Patel (Director), $14.1K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.35 on May 13, 2026.
Recent RVPH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 18, 2026 | Narayan Prabhu (CFO) | Bought (not open market) | — |
| Mar 18, 2026 | Laxminarayan Bhat (CEO) | Bought (not open market) | — |
| Mar 18, 2026 | Laxminarayan Bhat (CEO) | Bought (not open market) | — |
| Dec 18, 2025 | Parag Saxena (Director) | Bought (not open market) | — |
| Dec 18, 2025 | Richard A Margolin (Director) | Bought (not open market) | — |
| Dec 18, 2025 | Purav Patel (Director) | Bought (not open market) | — |
| Dec 18, 2025 | Leslie D. Funtleyder (Director) | Bought (not open market) | — |
Who's trading RVPH
- Laxminarayan Bhat, CEO: other filings, last Mar 18, 2026
- Narayan Prabhu, CFO: other filings, last Mar 18, 2026
- Parag Saxena, 10% owner: other filings, last Dec 18, 2025
- Leslie D. Funtleyder, Director: other filings, last Dec 18, 2025
- Richard A Margolin, Director: other filings, last Dec 18, 2025
- Purav Patel, Director: other filings, last Dec 18, 2025
Get free alerts when an insider at Reviva Pharmaceuticals Holdings, Inc files a new trade →